Multiple sclerosis is diagnosed through a combination of neurological exams, MRI scans, and sometimes spinal fluid testing, all guided by a standardized framework called the McDonald Criteria. There is no single test that confirms MS. Instead, doctors piece together evidence showing that the immune system has attacked the protective coating around nerves in at least two separate areas of the central nervous system. About 56% of patients receive a diagnosis within one month of their first symptoms, though for others the process can stretch over a year or more.
What Doctors Look for First
The diagnostic process typically begins after you experience a first episode of neurological symptoms, such as vision problems in one eye, numbness or tingling in your limbs, difficulty with balance, or unusual fatigue that doesn’t resolve. This first episode is called clinically isolated syndrome (CIS). To count as CIS, the episode must last at least 24 hours and result from inflammation and damage to the protective myelin coating on nerves in the brain or spinal cord.
A neurologist will perform a detailed physical exam, testing your reflexes, coordination, eye movements, strength, and sensation. They’re looking for signs that your nervous system isn’t transmitting signals properly. But the physical exam alone can’t confirm MS. It mainly tells the neurologist where in the nervous system the damage might be, which guides the next round of testing.
MRI: The Most Important Diagnostic Tool
MRI is the cornerstone of MS diagnosis. It can reveal areas of damage, called lesions, in the brain and spinal cord that are invisible to any other test. These lesions appear as bright spots on certain MRI sequences and represent places where the immune system has stripped away the myelin insulation around nerve fibers.
For a diagnosis, lesions need to appear in specific locations within the central nervous system. The current diagnostic criteria recognize five regions: the periventricular area (near the fluid-filled spaces deep in the brain), the cortical and juxtacortical area (at or near the brain’s outer surface), the infratentorial brain (the lower portion including the brainstem and cerebellum), the spinal cord, and, as of the 2024 update, the optic nerve. Finding typical lesions in at least two of these five regions satisfies what’s called “dissemination in space,” meaning the disease has affected more than one part of the nervous system.
Your neurologist may also use a contrast dye during the MRI. Lesions that light up with contrast are actively inflamed, while older lesions don’t enhance. Seeing both enhancing and non-enhancing lesions on the same scan can demonstrate that damage has occurred at different points in time, not just during a single event.
The McDonald Criteria
The McDonald Criteria are the internationally accepted rules for diagnosing MS. Originally published in 2001 and revised several times since, the most recent update was finalized in 2024 and published in The Lancet Neurology in 2025. These criteria spell out exactly what combination of clinical and test evidence is needed to make the diagnosis with confidence.
Two core principles have historically driven the criteria. First, there must be evidence that damage has occurred in more than one location in the central nervous system (dissemination in space). Second, there must be evidence that damage has occurred on more than one occasion (dissemination in time). The second requirement existed to distinguish MS from conditions that cause a single inflammatory attack and never return.
The 2024 revision made a significant change: dissemination in time is no longer always required. If a person has a typical attack or progressive neurological worsening lasting 12 months or more, and typical lesions are found in at least four of the five recognized regions, a diagnosis can be made without proving that damage happened at separate time points. This change means some patients can be diagnosed faster, potentially starting treatment earlier.
The updated criteria also allow a diagnosis in people who were previously placed in a gray zone. If you were told you have CIS (a single episode of MS-like symptoms) or radiologically isolated syndrome (lesions found incidentally on an MRI done for another reason, with no symptoms), the 2024 criteria now provide a pathway to an MS diagnosis if enough supporting evidence exists.
Spinal Fluid Testing
A lumbar puncture, often called a spinal tap, collects a small sample of cerebrospinal fluid from the lower back. The lab analyzes it for oligoclonal bands, which are specific patterns of immune proteins produced inside the central nervous system. About 92% of people with MS test positive for these bands. Their presence indicates that the immune system is actively producing antibodies within the brain and spinal cord, which doesn’t happen in a healthy nervous system.
A positive result for oligoclonal bands can substitute for some of the MRI evidence in certain diagnostic scenarios. For instance, if your MRI shows lesions in the right locations but doesn’t clearly prove that attacks happened at different times, the presence of oligoclonal bands can fill that gap. A spinal tap isn’t required for every patient, but it’s especially useful in borderline cases or when the MRI findings are less clear-cut.
Eye Tests That Reveal Hidden Damage
The 2024 diagnostic update formally brought the optic nerve into the diagnostic framework, recognizing that MS frequently damages the nerves connecting the eyes to the brain. Three types of eye-related testing can now contribute to a diagnosis.
Visual evoked potentials (VEPs) measure how quickly electrical signals travel from your eyes to the visual processing area of your brain. You sit in front of a screen displaying a shifting checkerboard pattern while electrodes on your scalp record the brain’s response. In MS, the damaged myelin slows these signals down, producing a measurable delay. Studies show that delayed signals with a preserved waveform are a hallmark of established MS. In patients with optic neuritis (inflammation of the optic nerve), those with latency delays were far more likely to progress to MS: 36.4% progressed within one year compared to 0% of those with normal signal speed.
Optical coherence tomography (OCT) is a quick, painless scan that takes a cross-sectional image of the retina at the back of your eye. MS-related damage to the optic nerve causes measurable thinning of specific retinal layers. A difference between your two eyes in the thickness of the retinal nerve fiber layer (6 micrometers or more) or the ganglion cell layer (4 micrometers or more) can count as evidence of optic nerve involvement.
Orbital MRI, a focused scan of the eye socket, can directly visualize lesions on the optic nerve itself. Any of these three tests can establish optic nerve involvement as one of the five anatomical regions needed for diagnosis.
Ruling Out Conditions That Mimic MS
Several other conditions can produce symptoms and MRI findings that look remarkably similar to MS, so part of the diagnostic process is excluding these mimics. Two of the most important are neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody disease (MOGAD). Both cause inflammation in the brain, spinal cord, and optic nerves, but they require different treatments than MS.
Blood tests can identify specific antibodies linked to these conditions. The aquaporin-4 antibody is the key marker for NMOSD, while the MOG antibody identifies MOGAD. Both tests use a method called a cell-based assay and are highly specific when positive. One complication is that antibody levels can fluctuate. Up to 57% of MOGAD patients may test negative when they’re not in the middle of an active attack, so timing matters. If one of these conditions is suspected, your neurologist may repeat the blood test during a flare.
Other conditions that can look like MS include lupus, sarcoidosis, vitamin B12 deficiency, certain infections, and migraine with white matter changes on MRI. Blood work, clinical history, and the pattern of lesions on MRI all help distinguish these from MS.
How Long Diagnosis Takes
A national registry study found that the average time from first symptoms to an MS diagnosis was about 13 months, but this number is skewed by a subset of patients who waited much longer. The median was just one month, and roughly 56% of patients were diagnosed within that first month. The wide range reflects the reality that MS can look very different from person to person. Someone who arrives at the emergency room with clear-cut optic neuritis and whose MRI immediately shows classic lesions in multiple regions may be diagnosed within weeks. Someone whose early symptoms are vague, such as intermittent tingling or fatigue, may go through months of monitoring before enough evidence accumulates.
The 2024 criteria updates, by relaxing the requirement to prove damage at different time points and by adding new testing options like OCT, are expected to shorten the diagnostic timeline for many patients. Earlier diagnosis matters because starting treatment sooner is associated with better long-term outcomes in preserving neurological function.